Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Helsinn obtains orphan designation for pracinostat to treat AML

pharmaceutical-technologyJanuary 17, 2018

Tag: Helsinn , orphan drug

PharmaSources Customer Service